F-Star Therapeutics Inc
(FSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,366 | -11,564 | -9,712 | N/A | N/A |
| Depreciation Amortization | 118 | 88 | 42 | N/A | N/A |
| Accounts payable and accrued liabilities | -812 | 1,835 | -21 | N/A | N/A |
| Other Working Capital | -877 | 2,140 | 657 | N/A | N/A |
| Other Operating Activity | 3,118 | -710 | 1,657 | 0 | 0 |
| Operating Cash Flow | $-15,819 | $-8,211 | $-7,377 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -213 | -389 | -55 | N/A | N/A |
| Purchase Of Investment | -14,978 | -8,542 | N/A | N/A | N/A |
| Sale Of Investment | 8,684 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-6,507 | $-8,931 | $-55 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 2,975 | N/A | N/A |
| Debt Repayment | N/A | N/A | -506 | N/A | N/A |
| Common Stock Issued | 28,663 | 19,919 | 250 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -18 | 0 | 0 |
| Financing Cash Flow | $28,663 | $19,919 | $2,701 | $N/A | $N/A |
| Beginning Cash Position | 4,347 | 1,570 | 6,301 | N/A | N/A |
| End Cash Position | 10,684 | 4,347 | 1,570 | N/A | N/A |
| Net Cash Flow | $6,337 | $2,777 | $-4,731 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,819 | -8,211 | -7,377 | N/A | N/A |
| Capital Expenditure | -213 | -389 | -55 | N/A | N/A |
| Free Cash Flow | -16,032 | -8,600 | -7,432 | 0 | 0 |